, ,

Allogeneic mesenchymal stem cell therapy with laromestrocel in mild Alzheimer’s disease:a randomized controlled phase 2a trial

|

免责声明:本网站目的在于科普相关知识传播,非盈利性质,全部资料均来源于网络,如有侵权请联系删除